15 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
and Independence Rule 3526, “Communication with Audit Committees Concerning Independence”, and the Audit Committee has discussed with EY their independence … is available on our website at http://investor.aligos.com/corporate-governance/governance-overview.
Independence of the Board of Directors
S-3
EX-1.2
pqggnrr57n144 fskvc
4 Nov 21
Shelf registration
4:57pm
DEF 14A
0jgxaeb3dgpzjj8x9ns
27 Apr 21
Definitive proxy
4:15pm
10-K
aqyx7 awv2aoqm8z
23 Mar 21
Annual report
4:26pm
8-K
EX-3.2
uvws57zoevzrgyvgxzi9
20 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:03pm
424B4
potz8dba3jtv qgo
19 Oct 20
Prospectus supplement with pricing info
5:21pm
S-1/A
zjjn5m2yuhe4
9 Oct 20
IPO registration (amended)
5:26pm
S-1/A
EX-3.5
kvo3f7jyjn
9 Oct 20
IPO registration (amended)
5:26pm
S-1
u0lm3tw
25 Sep 20
IPO registration
5:27pm
DRS
8fcd9dd
26 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next